EP Patent

EP1630169A2 — Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production

Assigned to Polypeptide Laboratories AS · Expires 2006-03-01 · 20y expired

What this patent protects

The invention relates to a process for preparing a tripeptide, including a salt thereof, of the formula (IX) Boc-D-2Nal-D-4CIPhe-D-3Pal-OH (IX) comprising the following consecutive steps: (a) Reacting Boc-D-4ClPhe-OH with HONSu to form Boc-D-4ClPhe-OSu (VII); (b) Reactin…

USPTO Abstract

The invention relates to a process for preparing a tripeptide, including a salt thereof, of the formula (IX) Boc-D-2Nal-D-4CIPhe-D-3Pal-OH (IX) comprising the following consecutive steps: (a) Reacting Boc-D-4ClPhe-OH with HONSu to form Boc-D-4ClPhe-OSu (VII); (b) Reacting Boc-D-4ClPhe-OSu (VII) with H-D-3Pal-OH to form Boc-D-4ClPhe-D-3Pal-OH (VIII); (c) Reacting Boc-D-4ClPhe-D-3Pal-OH (VIII) with Boc-D-2Nal-OSu prepared by reacting Boc-D-2Nal-OH with HONSu to form Boc-D-2Nal-D-4ClPhe-D-3Pal-OH (IX).

Drugs covered by this patent

Patent Metadata

Patent number
EP1630169A2
Jurisdiction
EP
Classification
Expires
2006-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Polypeptide Laboratories AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.